May 6 |
Gossamer Bio Collaborates With Italian Drugmaker Chiesi To Advance Lung Health Solutions Worldwide
|
May 6 |
UPDATE 1-Gossamer Bio and Chiesi Group to collaborate in therapy for lung condition
|
May 6 |
Gossamer sells rights to drug it hopes can rival a new Merck therapy
|
May 6 |
Gossamer Bio and Chiesi Group Announce Transformative Global Collaboration to Develop and Commercialize Seralutinib in PAH, PH-ILD & Other Indications
|
May 3 |
Gossamer Bio Announces Publication of TORREY Phase 2 Results in the Lancet Respiratory Medicine
|
Apr 26 |
Gossamer Bio Decline Means Insider Profits Down To US$17k
|